SUMMARY Arabinitol concentrations were determined in 157 serum samples from 95 patients with suspected invasive candidosis and in 10 serum samples from healthy laboratory workers. Fifty eight of the 95 patients, subsequently diagnosed as not having invasive candidosis had concentrations of arabinitol below 1 2 pg/ml (mean 0-59 (SD) 0-26). Sera from the healthy laboratory workers gave similar results (mean 0-55 (0-05) 
The diagnosis of serious Candida infections is unsatisfactory in many hospitals and often depends on circumstantial evidence of variable quality, including the persistent isolation of yeasts from normally sterile sites, proof of a rising antibody titre, repeated positive blood cultures, and clinical signs of an infection that persists despite apparently appropriate antibacterial treatment.' 2 Reliance on such criteria leads to missed or delayed diagnosis.34 The isolation of yeasts from some sites can be misleading and may reflect contamination from nearby sites of colonisation. Serological methods have been described by many workers but doubts remain with respect to their specificity and the interpretation of results.' Histological evidence of tissue invasion by biopsy is often unavailable either because the patient is too ill for the procedure to be attempted or because the site is poorly identified or unapproachable.3 More specific methods of immunodiagnosis are currently under investigation, including detection of circulating antigens by latex agglutination, and enzyme or radioimmunoassay, and these have recently been reviewed by de Repentigny and Reiss.6 Rapid and accurate diagnosis of systemic candidosis is essential if reductions in morbidity or mortality Accepted for publication 26 March 1986 are to be achieved; recent reports have suggested that gas-liquid chromatography may contribute to this end.7-I In 1979-80 two groups89 independently reported that the major metabolite of the clinically important Candida species, both in vivo and in vitro, was the polyol, D-arabinitol, derived from the metabolism of carbohydrates.'0 Both groups found that the normal concentrations of D or L-arabinitol in the serum of healthy control groups or of patients with simple colonisation or superficial infections were consistently less than 10 pg/ml. By contrast, patients (and animals) with confirmed systemic disease showed concentrations that were usually greater than 1-0 pg/ml. Patients in renal failure but without detectable systemic candidosis were also found to have increased concentrations of the metabolite in their sera .8 9 Subsequently, two prospective studies evaluated the approach under clinical conditions of usage" 12; and the Sloan Kettering group extended their original studies by investigating the incidence of arabinitol and arabinitol:creatinine (a:c) ratios in renal failure both in an animal model and in 25 patients with Diagnosing invasive candidosis the clinical microbiology laboratory of a large general hospital on sera obtained from patients in six Scottish hospitals in the Glasgow and Edinburgh regions.
Patients and methods
One hundred and fifty seven sera from 95 patients in hospitals in the Glasgow and Edinburgh regions were studied. More than one serum sample was obtained from 33 patients. Six sets of sera were obtained retrospectively (principally sent by Dr HJR Milne, mycologist at the Western General Hospital, Edinburgh) after invasive candidosis had been diagnosed and these were processed without knowledge of the patients' condition or other findings. All other sera were examined prospectively and were obtained from patients suspected of developing invasive candidosis. Increasingly, as the study progressed, the evaluation of the technique was linked with its use as an aid to diagnosis.
In preparing this paper, patients' case histories were reviewed and placed into one of three groups: patients who did not have invasive candidosis; patients with confirmed or probable invasive candidosis; and candidaemic patients with clinical signs of systemic infection who had infected intravenous lines or cannulas.
The criteria accepted as independent proof of invasive candidosis were histological and obtained either by biopsy or at necropsy. In the absence of histology documented cases of invasive candidosis were established by a combination of clinical and laboratory evidence. All the patients in this group were clinically judged to have invasive candidosis, but due to the variability of case presentations no absolute set of criteria could be used; each case, however, was carefully assessed using well recognised and established criteria.' -3 5 All had received steroids or cytotoxic drugs for underlying diseases such as carcinoma or leukaemia, or had received prolonged treatment with antibiotics for the treatment or prevention of bacterial infections, or a combination of the above. All showed clinical signs of a systemic infection, including a persistent and often fluctuating fever, and were not responding to broad spectrum antibiotics. Other evidence evaluated included the isolation (preferably repeated) of high numbers of yeasts from blood cultures or other normally sterile deep sites such as abscess, peritoneal fluid, lung aspirate, or urine; recorded observations of a clinical response to systemic antifungal drugs, or a significant rise in anticandidal antibody titres. In two heroin addicts fundiscopic signs of a typical candida endophthalmitis were accepted as evidence of a locally invasive infection,5 and three patients with peritoneal candidosis associated with continuous ambulatory peritoneal 843 dialysis (CAPD) had > 10' colony forming units/ml of yeasts in three consecutive fluids, persistent leucocytosis, and peritoneal signs of infection.18 The use of the general terms "systemic" and "deep seated" is conventional and consistent with that of Odds' and other workers.3 GAS-LIQUID CHROMATOGRAPHY All gas-liquid chromatographic analyses were performed using a Perkin Elmer Sigma 3 gas chromatograph fitted with dual flame ionisation detectors and two 2-0 metre x 4mm outer diameter glass columns packed with 3% SE 30 on 80/100 mesh Chromosorb W-HP (Chromatograpy Services Ltd, Hoylake, Merseyside, England). The nitrogen carrier rate was 20 ml/minute and the oven temperature was programmed to rise from 140°C to 200°C at 4°/minute.
SAMPLE PROCESSING AND STANDARDISATION
Serum arabinitol concentrations were measured using a modification of the method described by Kiehn etal.89 Thus 200 p1 of serum were mixed with 400 p1 of acetone containing 5 0pg/ml of internal standard in a glass stoppered centrifuge tube. The precipitated proteins were removed by centrifuging the mixture at 1500g for five minutes; the supernatant was collected into another glass centrifuge tube and dried at 500C under a stream of oxygen free nitrogen (OFN). Trimethylsilyl derivatives (TMS) were then prepared by adding 0-1 ml of a 9:3:1 mixture of pyridine, hexamethyldisilazine, and trimethylchlorosilane (Sylon HTP, Supelco, available from RB Radley and Co Ltd, England) and incubated at room temperature for 30 minutes. This mixture was then dried again under OFN at 50°C and resuspended in 0-12 ml of pure diethyl ether19 (anhydrous puriss, AR Koch-Light Laboratories Ltd). 3 0 p1 of this extract were immediately injected into the gas chromatograph.
The internal standards were a-methyl-Dmannopyrannoside and f-methyl-D-xyloside (Sigma).13 14 An external standard consisting of pooled normal human serum containing arabinitol to a final concentration of 5-0.ug/ml was processed periodically as required to monitor any variations in sensitivity or flow rates. Arabinitol concentrations in test sera were calculated by comparing them with the peak height of an external standard processed on the same day after correcting for differences in the height of the internal standard in the test and control samples. All calculations of arabinitol concentration were based on manual measurements of peak heights. A substantial number of results (about 70%) reported in this paper were confirmed by replicate analyses on the same day; this practice, however, was discontinued later in the 844 study. In preliminary trials retention times and relative response factors for arabinitol and the internal standards were established by preparing a set of standard solutions of arabinitol in distilled water at concentrations of 2-0, 40, 5.0, 6-0, and 8 0 pg/ml and treating these as for a serum specimen. Repeated analyses, with a minimum of four at each concentration, showed a linear correlation between peak height and concentration over the range of concentrations tested. The overall experimental error was 0-02 and the mean (SD) ratio of observed:expected value of arabinitol measured against the a-methyl-Dmannoside internal standard was 094 (0 1 1). A typical series of routine analyses of the 5 pg/ml pooled serum standard taken over two months showed a mean (SD) ratio of observed:expected values of 090 (008). There was no significant difference in the reproducibility of the aqueous or serum standards as determined by the Siegel and Tukey modification of the Wilcoxon sum of rank tests.20 All serum specimens were held at +4°C until processing and then stored at -20°C. Creatinine results were those reported on the same day that the serum for arabinitol estimations was collected.
Results

NORMAL SERA
Ten serum samples from normal healthy laboratory workers yielded arabinitol concentrations of less than [Opg/ml (mean 0 55 (0-05)).
PATIENTS FOR WHOM A DIAGNOSIS OF INVASIVE CANDIDOSIS WAS EXCLUDED
Fifty eight of the 95 patients studied had arabinitol concentrations below 1-2 Mg/ml and were considered not to have invasive candidosis. The range of arabinitol concentrations found in the serum samples of these patients, who all had normal renal function, was 0-1-0 with a mean (SD) of 0 59 (0-26)-where more than one specimen was examined only the maximum value was used in these calculations. By applying the mean + 2 SD rule the upper limits of normal for patients without a systemic infection and with normal renal function was estimated as 1 1 (0 59 + 0-52).
A further 10 patients were not thought to have invasive infections on clinical or laboratory grounds but had arabinitol concentrations > 1-2 pg/ml. The maximum value obtained in this group was 4-0 pg/ml. Nine had clinically important renal failure (creatinine concentrations > 132 pmol/1). Five were heavily colonised with yeasts and four had been treated with antibiotics for bacterial sepsis. The remaining patient, with an arabinitol concentration of 13 Mg/ml, seemed to have given a false positive result-a child who was feverish, not responding to antibiotics after a bone Deacon marrow transplant, but who had no other evidence of fungal infection and recovered without antifungal treatment. Table 1 shows the important clinical and laboratory evidence and the results of arabinitol testing for 27 patients who had signs of systemic or localised invasive candidosis. Confirmation from necropsy or biopsy findings was available for six cases only, but a total of 19 cases that met the criteria described previously were accepted as cases of confirmed or probable invasive candidosis. The remaining eight also had signs of systemic infection and met the designated criteria, but these were more difficult to assess because of candidaemia associated with infected intravenous lines or cannulas; and these were placed in a separate subgroup ( More than one serum sample was obtained from 33 patients in the study. Multiple samples were obtained from 10 adults and two children in the invasive group and from two children and two infants in the probably invasive but candidaemic subgroup. Increases in arabinitol concentration in a patient's serum often occurred at or about the time that yeasts were detected in blood cultures. In the cases where the first positive arabinitol result coincided with the first positive blood culture the arabinitol result was available on the day of sampling, whereas the blood culture result was not known until 48-72 hours later. The findings reported here confirm and extend the observations of previous investigators.'5 ARABINITOL AND RENAL FAILURE During this study Wong etal'4 described the 1:1 relation between arabinitol and creatinine excretion under conditions of normal renal function and in a later paper, that an arabinitol:creatinine (a:c) ratio of 1 4:1 was the lower limit of significance that was consistent with invasive candidosis in a patient with renal impairment.'5 In this study eight of the 27 patients exhibited clinically important renal failure (Table 1) . Arabinitol concentrations in these patients were generally higher than in patients with normal renal function, although the highest individual concentra- tions of 95 jug/ml was from a patient without renal problems at the time. Table 2 shows the results obtained with a group of six patients in renal failure who were not receiving dialysis. All creatinine results were converted from (pmol/l) to traditional (mg/dl) units, using the multiplication factor of 001 13 before calculating the a:c ratio, as described by Wong etal.'4 In the colonised or superficially infected cases and in the case of candidaemia (case 4) the a:c ratios were < 0, suggesting that the raised arabinitol concentrations ( > 1 0 jg/ml) in two of the three cases were caused by renal failure rather than invasive disease. This conclusion was also consistent with the clinical findings in each case. The a:c ratio exceeded 1-2 in two of the three invasive cases but only in one did it exceed 1-4, the lowest value of likely significance suggested by Gold et al.15 Table 3 gives the detailed results obtained from the sera of three patients undergoing CAPD with confirmed candida peritonitis. Raised arabinitol concentrations were found in all three patients. (The sera from the patient with Cparapsilosis peritonitis were taken only after the patient had completed a 21 day course of ketoconazole.) The single set of paired predialysis and post dialysis sera obtained from one patient (case 3) showed that on this occasion there was only a relatively small reduction in the serum arabinitol concentration.
PATIENTS WITH CONFIRMED OR PROBABLE INVASIVE CANDIDOSIS
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Discussion
The publication of techniques for the estimation of D-arabinitol concentrations in patients' sera and the evidence that this polyol is a major metabolite of the clinically important Candida species of yeasts were important developments in the search for new and more specific techniques for the diagnosis of invasive candidosis. The present study was undertaken to evaluate this approach prospectively and was carried out without prior selection of the patients included on the basis of any particular underlying disease. The lack of selection simulates the likely use of the test in a diagnostic laboratory context. This study confirms that arabinitol is present in small amounts in the sera of uninfected and otherwise healthy subjects, as well as in patients who are colonised, or superficially infected, with strains of Preliminary results with patients on dialysis suggest that there will be other difficulties of interpretation in these patients. It is not clear whether the a:c ratio can be reliably applied to patients receiving either CAPD or haemodialysis. As shown in the results (Table 3) there is some evidence that the serum concentrations of creatinine fall more quickly than that of arabinitol during dialysis. Eng et al" also reported a case in which there was only a small decrease in the arabinitol concentration after dialysis.
It is not possible to quote accurate figures for the sensitivity or specificity of the analysis, when proof of invasiveness is not available for most clinically invasive cases, but if the 27 cases detailed in Table I are accepted as positives for the purposes of approximation the sensitivity is 92-5% and the specificity 88-2%. These results confirm the findings of Gold et al, ' The normal range for serum arabinitol in the serum of infants has yet to be established, and it is possible that the normal concentrations in infants will not prove to be the same as those in adults. Factors such as the age of the infant, the immaturity of the kidneys or some metabolic functions, or relatively short term changes in the state of hydration may affect the amounts of arabinitol detected in a random sample of serum. Further studies are in progress.
The observation that the arabinitol concentrations in the cerebrospinal fluid of one child were higher than in her serum was unexplained at the time, but the results suggested a baseline value of 3-0 pg/ml. No inborn errors of pentose metabolism had been detected23 and there were no published normal values, but there had been one isolated report of similar raised concentrations in a case of candida meningitis.l" Subsequently, the Sloan Kettering group confirmed that the normal values in cerebrospinal fluid were higher with a mean of about 3 04ug/ml (D Armstrong, personal communication). Scheld et al24 then reported that the mean normal value in the cerebrospinal fluid of rabbits and of man was 3-4 (02) ug/ml (mean (SD)). To date results on six cerebrospinal fluid samples from children and adults in this laboratory show a similar pattern (unpublished data).
In common with other infectious diseases, the development of systemic candidosis in a patient is likely to be determined by the interplay between factors such as the number of infecting yeasts at the site, the availability of nutrients, the growth rates and virulence of the infecting strain, and the host defences."" s Similarly, the production of abnormally high amounts of serum arabinitol will also depend on these factors and on the rate of its excretion by the kidneys.'5 Such complex interactions 850 readily explain why the test occasionally fails to confirm a positive diagnosis, or only yields a positive finding late in the disease process. Another cause of false negative or delayed positive results may be due to quantitative differences in the amounts of arabinitol produced by different strains or species of yeasts. 1 False positive results may occur when there is a heavy superficial colonisation, or infection restricted to superficial mucosa in tissues that are normally sterile. Some evidence was seen during this study, which suggested that such circumstances could arise in patients with large areas of trauma leading to extensive colonisation of normally internal surfaces. It is also possible that intestinal obstruction occurring in a patient who is colonised with yeasts could lead to an overgrowth in the gut with very high numbers of yeasts producing greater than normal amounts of arabinitol. Even if only a proportion of this was absorbed from the gut it could lead to increased serum concentrations in a patient with normal renal function. Such findings in patients with complex clinical problems undergoing a high degree of medical manipulation or receiving extensive supportive treatment can pose major difficulties in interpreting laboratory results.
It is possible that the limitations of this approach, identified in this and other similar studies in the United States,8 911 may be compensated for by the concurrent use of other recently described methods for diagnosis, including the detection of circulating antigen by latex agglutination,25 enzyme linked immunoassay or radioimmunoassay for antigen or antibody detection,26-28 or by a combination of the arabinitol approach with other gas-liquid chromatography methods.'6 17 At present a full diagnostic service in this difficult area seems to require a combination of techniques, and the results of this study suggest that arabinitol estimations are worthy of careful consideration in those laboratories that are appropriately equipped.
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